April 29 (Reuters) - Swiss dental implants maker Straumann STMN.S on Wednesday reported first quarter sales above expectations, citing strong momentum in implant sales.
Revenue declined to 673 million Swiss francs ($853 million) in the first quarter, down 1.2% but up 7.1% organically, beating analysts' estimate of 665.5 million francs in a Vara consensus.
The company confirmed its 2026 guidance, expecting high single digit organic revenue growth and an earnings margin improvement of 30 to 60 basis points.
($1 = 0.7889 Swiss francs)
(Reporting by Cian Muenster and Bartosz Dabrowski)
((Cian.Muenster@thomsonreuters.com;))